Full Text View
Tabular View
No Study Results Posted
Related Studies
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
This study has been completed.
Study NCT00382460   Information provided by Bristol-Myers Squibb
First Received: September 27, 2006   Last Updated: June 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Actue Coronary Syndromes
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
Pathologic Processes
Interventions listed in this trial
PRAVASTATIN SODIUM
Additional drug interventions recognized in this trial
Atorvastatin
Pravastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services